Daily Newsletter

28 November 2023

Daily Newsletter

28 November 2023

Myocene signs contract with OGC Nice football club

Myocene scores big with new contract to supply OGC Nice with its medical device for measuring muscle fatigue.

Kiays Khalil

The transfer window isn’t closed. Professional French Ligue 1 football team OGC Nice has signed a contract with sports technology firm, Myocene to provide the club with its muscle fatigue technology.

The company develops wearable devices to measure muscle fatigue and performance using patented algorithms and artificial intelligence (AI) to track patient data and can calculate an athlete’s muscle fatigue index in two minutes through muscle electrostimulation and force sensors.

Muscle fatigue can be treated with multiple medical devices, but it can also be a symptom of an underlying medical conditions like such as Long Covid, fibromyalgia and neurological disorders like amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). The Myocene device can be used in the in this area to treat some of these muscle disorders.

The Interuniversity Laboratory of Motor Biology (LiBM), Saint-Etienne, France published an article scientifically validating the use of the Myocene device in April 2023. The study on nearly 1000 athletes was validated by Guillaume Millet, a sports physiologist at the Jean Monnet University in Saint-Etienne in France and concluded it was safe for use monitoring fatigue in athletes.

Co-author of the paper Millet said: “Our future work will focus on demonstrating how, with this innovative tool, it is possible to measure fatigue regularly and objectively in athletes who train frequently. Monitoring fatigue is essential to adapt the training loads of athletes.”

The Ligue 1 club will use Myocene’s technology in training sessions and on the pitch during game days. Data will be collected each week to manage player recovery levels while giving management a better understanding when an individual needs to miss training or an upcoming game.

Laurent Bessiere, performance director at OGC Nice said: “We chose Myocene’s device as a tool that allows us to reliably assess the players’ ‘freshness’ and recovery levels.”

This latest signing follows a string of contracts with professional sports clubs like French handball clubs Saint-Raphaël Var Handball (SRVHB) and US Ivry, and the French and Portuguese football clubs RC Strasbourg and Sporting Clube de Braga.


In May 2023, Myocene raised €2 million ($2.2M) in its third seed funding round, bringing their total funding to €3.3 million ($3.6M).

The aging population is a captive market for medical devices

The rising number of older individuals globally is accompanied by increasing health concerns, presenting unique demand for the medical device industry. With rising pressure on governments, payers, and manufacturers to reduce healthcare costs, innovative medical technologies have tremendous potential to improve elder care. Advancements in medical device technology have resulted in a significant increase in the number of conditions that can be managed in a home care setting. To capitalize on this strong demand and growth, manufacturers are increasingly producing consumer-targeted equipment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Vist our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close